Stereotaxis Announces Heart Centre Rigshospitalet Enhances Leadership In Patient Care With Adoption of Latest Robotic Technology
Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that physicians at Heart Centre Rigshospitalet of Copenhagen University